Results 121 to 130 of about 21,299 (206)

CYP2C19 genotype-guided antiplatelet therapy to prevent thromboembolic events after stent-assisted coil embolization of unruptured intracranial aneurysms: a retrospective cohort study. [PDF]

J Neurointerv Surg
Yang M, Zhang X, Xu J, Wang Y, Lin T, Xu H, Chen J, Dai Y, Yu L, Wei Z, Zhu T, Hu W, Hu Y, Xu D, Dai H.   +14 more
europepmc   +1 more source

CYP2C19*3 Allele [PDF]

, 2020
openaire   +1 more source

Limited Visibility and Perception of the Clinical Relevance of Clopidogrel Pharmacogenetics in Cardiology Literature. [PDF]

Clin Transl Sci
Dello Russo C, Venetucci L, Akintola A, Gagliardi D, Ramlogan R, Pirmohamed M.   +5 more
europepmc   +1 more source

Cardiovascular prescriber attitudes to pharmacogenomics: a survey by the ESC working group on cardiovascular pharmacotherapy. [PDF]

Pharmacogenomics J
Magavern EF, Dan GA, Savarese G, Borghi C, Dobrev D, Tamargo J, Ferdinandy P, McDermott JH, Newman WG, Pirmohamed M, Caulfield MJ, Kaski JC.   +11 more
europepmc   +1 more source

CYP2C19*9 Allele [PDF]

, 2020
openaire   +1 more source

Pharmacogenetics of antidepressant response: a focused review on CYP2C19, CYP2D6, SLC6A4, and HTR2A polymorphisms. [PDF]

Front Pharmacol
Blambila L, Sabei P, Raulino VG, Herkenhoff ME.   +3 more
europepmc   +1 more source

CYP2C19*12 Allele [PDF]

, 2020
openaire   +1 more source

Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy. [PDF]

J Antimicrob Chemother
Wehbe E, Sreeharan T, Sutrave G, Bui J, Lau C, Park JY, Sandaradura I, Darley D, Macdonald P, Milliken S, Fung JN, Jones G, Kizny Gordon A, Kliman D, Lu CY, Marriott D, Alffenaar JC, Stocker SL.   +17 more
europepmc   +1 more source

CYP2C19 genotype and cardiovascular events.

JAMA, 2012
Siasos, Gerasimos, Tousoulis, Dimitris, Stefanadis, Christodoulos   +2 more
openaire   +2 more sources

CYP2C19*7 Allele [PDF]

, 2020
openaire   +1 more source